These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7892497)

  • 1. Probable Alzheimer disease: diagnosis with proton MR spectroscopy.
    Shonk TK; Moats RA; Gifford P; Michaelis T; Mandigo JC; Izumi J; Ross BD
    Radiology; 1995 Apr; 195(1):65-72. PubMed ID: 7892497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.
    Ernst T; Chang L; Melchor R; Mehringer CM
    Radiology; 1997 Jun; 203(3):829-36. PubMed ID: 9169712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
    Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW
    Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comments on use of H-1 MR spectroscopy for diagnosis of probable Alzheimer disease.
    Resnick SM; Costa PT
    Radiology; 1995 Apr; 195(1):14-5. PubMed ID: 7892455
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
    Fayed N; Dávila J; Oliveros A; Castillo J; Medrano JJ
    Acad Radiol; 2008 Sep; 15(9):1089-98. PubMed ID: 18692749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
    Watanabe T; Shiino A; Akiguchi I
    Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy.
    Miller BL; Moats RA; Shonk T; Ernst T; Woolley S; Ross BD
    Radiology; 1993 May; 187(2):433-7. PubMed ID: 8475286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1H MR spectroscopy in common dementias.
    Kantarci K; Petersen RC; Boeve BF; Knopman DS; Tang-Wai DF; O'Brien PC; Weigand SD; Edland SD; Smith GE; Ivnik RJ; Ferman TJ; Tangalos EG; Jack CR
    Neurology; 2004 Oct; 63(8):1393-8. PubMed ID: 15505154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
    Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
    NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
    Modrego PJ; Fayed N; Pina MA
    Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
    Arana E; Martínez-Granados B; Marti-Bonmati L; Martínez-Bisbal MC; Gil A; Blasco C; Celda B
    Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy.
    Geissler A; Fründ R; Kohler S; Eichhorn HM; Krämer BK; Feuerbach S
    Radiology; 1995 Mar; 194(3):693-7. PubMed ID: 7862964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of 1H spectroscopy to a brief cognitive-functional test battery for the diagnosis of mild Alzheimer's disease.
    Silveira de Souza A; de Oliveira-Souza R; Moll J; Tovar-Moll F; Andreiuolo PA; Bottino CM
    Dement Geriatr Cogn Disord; 2011; 32(5):351-61. PubMed ID: 22311276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
    Metastasio A; Rinaldi P; Tarducci R; Mariani E; Feliziani FT; Cherubini A; Pelliccioli GP; Gobbi G; Senin U; Mecocci P
    Neurobiol Aging; 2006 Jul; 27(7):926-32. PubMed ID: 15936850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.